Amrutanjan Health Care Fair Value
Amrutanjan Health Care (AMRUTANJAN) average fair value is ₹666.72 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹559.95 (+19.07%), fair value range ₹363.33–₹970.1. For live price and a broader fundamental view, visit Amrutanjan Health Care screener.
Fair Value Analysis Export
AMRUTANJAN Fair Value vs Current Price — Valuation Summary
AMRUTANJAN average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. Also explore Amrutanjan Health Care share price performance to track price trends across different timeframes.
P/B Based Valuation
Asset-Based Valuation
AMRUTANJAN Fair Value Analysis — Data Sources & Coverage
Amrutanjan Health Care financial data sources, valuation methods applied and sector benchmarks used. See AMRUTANJAN P/B ratio history to compare market price against book value per share.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
AMRUTANJAN vs Healthcare Sector Peers — P/E, P/B & Market Cap
Amrutanjan Health Care P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Accretion Pharmaceuticals | ACCPL | 13.72 | 2.43 | ₹131 |
| Par Drugs & Chemical | PAR | 8.67 | 1.01 | ₹111 |
| Jeena Sikho Lifecare | JSLL | 40.02 | 22.33 | ₹7,891 |
| Auro Laboratories | AUROLAB | 91.49 | 3.91 | ₹165 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.